Biomedical engineers have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing proteins. Inspired by ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...

Eldiara Doucette, a TikTok star who details her journey with rare cancer synovial sarcoma online, shared a lighthearted ...

Nagpur: In a remarkable achievement, AIIMS Nagpur successfully treated a 26-year-old MBBS student suffering from synovial cell sarcoma, a rare and aggressive cancer affecting the chest wall. The young ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell therapy targeting the NY-ESO-1 antigen. This support will include activities ...

The American Cancer Society's estimates for soft tissue sarcomas in the United States for 2025 are: About 13,520 new soft tissue sarcomas will be diagnosed (7,600 in males and 5920 in females). About ...

Adaptimmune CEO Adrian Rawcliffe said during the JP Morgan Healthcare Conference on Tuesday that the firm expects to begin the process of submitting a rolling biologics license application to the FDA ...

Adaptimmune Therapeutics in August 2024 secured FDA approval for the first engineered T cell therapy for solid tumor cancers in the U.S. Tecelra is also the first new therapeutic option for synovial ...